Abstract
Chromosomal translocations entail the generation of gene fusions in solid mesenchymal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. Herein these studies are reviewed using FUS-CHOP as a model to illustrate how the manipulation of their loci in the mouse has contributed to the current understanding in unique and unexpected ways. FUS-CHOP is a chimeric oncogene generated by the most common chromosomal translocation t(12;16)(q13;p11) associated to liposarcomas. The application of transgenic methods to the study of this sarcoma-associated FUS-CHOP gene fusion has provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved.
Keywords: mesenchymal cancer, fus-chop, chimeric oncogene, liposarcomas
Current Genomics
Title: Understanding Mesenchymal Cancer: The Liposarcoma-Associated t(12;16) (q13;;p11) Chromosomal Translocation as a Model
Volume: 3 Issue: 4
Author(s): P. A. Perez-Mancera, J. Perez-Losada, M. A. Sanchez-Martin, A. Rodriguez-Garcia, R. Jimenez and I. Sanchez-Garcia
Affiliation:
Keywords: mesenchymal cancer, fus-chop, chimeric oncogene, liposarcomas
Abstract: Chromosomal translocations entail the generation of gene fusions in solid mesenchymal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. Herein these studies are reviewed using FUS-CHOP as a model to illustrate how the manipulation of their loci in the mouse has contributed to the current understanding in unique and unexpected ways. FUS-CHOP is a chimeric oncogene generated by the most common chromosomal translocation t(12;16)(q13;p11) associated to liposarcomas. The application of transgenic methods to the study of this sarcoma-associated FUS-CHOP gene fusion has provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved.
Export Options
About this article
Cite this article as:
Perez-Mancera A. P., Perez-Losada J., Sanchez-Martin A. M., Rodriguez-Garcia A., Jimenez R. and Sanchez-Garcia I., Understanding Mesenchymal Cancer: The Liposarcoma-Associated t(12;16) (q13;;p11) Chromosomal Translocation as a Model, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350417
DOI https://dx.doi.org/10.2174/1389202023350417 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
Current Stem Cell Research & Therapy High-Throughput Techniques for Identifying microRNA Target Genes
Current Bioinformatics Innate Immunity and Intracellular Trafficking: Insights for Novel Anti- HIV-1 Therapeutics
Current Pharmacogenomics Epigenetic Targets and their Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry Current Management of Neonatal Soft-tissue Sarcomas and Benign Tumors with Local Aggressiveness
Current Pediatric Reviews The HIV-1 Capsid Protein as a Drug Target: Recent Advances and Future Prospects
Current Protein & Peptide Science Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo
Letters in Drug Design & Discovery Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery
Current Nanoscience Implication of Unfolded Protein Response and Autophagy in the Treatment of BRAF Inhibitor Resistant Melanoma
Anti-Cancer Agents in Medicinal Chemistry Comparison of Uptake Mechanisms for Anthracyclines in Human Leukemic Cells
Current Drug Delivery AIDS-Related Kaposis Sarcoma: State of the Art and Therapeutic Strategies
Current HIV Research mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Plasticity of T Cell Differentiation and Cytokine Signature: A Double-Edged Sword for Immune Responses
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Crosstalk Signalling Role in Modulation of Drugs Side Effects
Current Molecular Pharmacology Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
Current Signal Transduction Therapy Recent Trends in Targeted Anticancer Prodrug and Conjugate Design
Current Medicinal Chemistry Impact of Quaternary Structure Dynamics on Allosteric Drug Discovery
Current Topics in Medicinal Chemistry Autophagy Regulators as Potential Cancer Therapeutic agents: A Review
Current Topics in Medicinal Chemistry FAK and Interacting Proteins as Therapeutic Targets in Pancreatic Cancer
Anti-Cancer Agents in Medicinal Chemistry